Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

TPEX/4107 stock hub

TPEX/4107 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4107is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.1B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4107

In the news

Latest news · TPEX/4107

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.4

P25 12P50 15.5P75 22.5

Trailing P/E15.1

P25 14.4P50 18P75 31.9

ROE15.3

P25 -16.2P50 0.3P75 9.8

ROIC21

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4107 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

240

Groups with data

Currency

TWD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 7B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	TW0004107008
Last refreshed	2026-05-10
Market cap	TWD 8.1B
Price	TWD 117
Price currency	TWD
Sector	Healthcare
Sic	3841
Symbol	tpex/4107
Website	https://www.bioteq.com.tw/zh-tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.65%
EV Earnings	13.05x
EV/EBIT	10.5x
EV/EBITDA	8.36x
EV/FCF	11.6x
EV/Sales	3.3x
FCF yield	7.49%
Forward P/E	14.41x
P/B ratio	2.25x
P/E ratio	15.12x
P/S ratio	3.8x
PE Ratio10 Y	19.17x
PE Ratio3 Y	16.71x
PE Ratio5 Y	16.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	31.39%
EBITDA Margin	38.66%
FCF margin	28.42%
Gross margin	43.88%
Gross Profit	TWD 936.9M
Gross Profit Growth	3.52%
Gross Profit Growth Q	9.58%
Gross Profit Growth3 Y	3.52%
Gross Profit Growth5 Y	1.92%
Net Income	TWD 539.2M
Net Income Growth	2.07%
Net Income Growth Q	15.89%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Net Income Growth3 Y	2.99%
Net Income Growth5 Y	1.99%
Pretax Margin	31.59%
Profit Margin	25.25%
Profitable Years	20
ROA	9
Roa5y	8.71
ROCE	16.3
ROE	15.3
Roe5y	15.69
ROIC	21.03
Roic5y	20.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.02%
Cagr15y	8.95%
Cagr1y	-3.04%
Cagr20y	17.13%
Cagr3y	4.36%
Cagr5y	3.42%
Div CAGR10	6.76%
Div CAGR3	3.57%
Div CAGR5	4.56%
EPS Growth	1.98
EPS Growth Q	15.46
EPS Growth Quarters	1
EPS Growth Years	2
EPS Growth3 Y	2.97
EPS Growth5 Y	1.97
FCF Growth	0.42%
FCF Growth Q	-23.43%
FCF Growth5 Y	5.58%
OCF Growth	-5.47%
OCF Growth Q	-11.82%
OCF Growth10 Y	5.59%
OCF Growth3 Y	1%
OCF Growth5 Y	0.92%
Revenue Growth	3.03x
Revenue Growth Q	12.48x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	2.03x
Revenue Growth5 Y	1.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.46
Assets	TWD 4.7B
Cash	TWD 1.7B
Current Assets	TWD 2.3B
Current Liabilities	TWD 546.7M
Debt	TWD 597.4M
Debt EBITDA	TWD 0.71
Debt Equity	TWD 0.17
Debt FCF	TWD 0.98
Equity	TWD 3.6B
Interest Coverage	88.88
Liabilities	TWD 1.1B
Long Term Assets	TWD 2.3B
Long Term Liabilities	TWD 506.2M
Net Cash	TWD 1.1B
Net Cash By Market Cap	TWD 13.19
Net Cash Growth	24.97%
Net Debt EBITDA	TWD -1.3
Net Debt Equity	TWD -0.3
Net Debt FCF	TWD -1.76
Tangible Book Value	TWD 3.6B
Tangible Book Value Per Share	TWD 52.05
WACC	4.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.27
Inventory Turnover	3.9
Net Working Capital	TWD 277.1M
Quick ratio	3.64
Working Capital	TWD 1.8B
Working Capital Turnover	TWD 1.24

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.09%
Dividend Growth	11.11%
Dividend Growth Years	1%
Dividend per share	TWD 5.5
Dividend Years	19
Dividend Yield	4.7%
Ex Div Date	2026-07-28
Last Dividend	TWD 5
Payout Frequency	Annual
Payout Ratio	64.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-0.24%
1Y total return	-3.03%
200-day SMA	119.5
3Y total return	13.66%
50-day SMA	119
50-day SMA vs 200-day SMA	50under200
5Y total return	18.32%
All Time High	173
All Time High Change	-32.37%
All Time High Date	2016-04-21
All Time Low	4.51
All Time Low Change	2,495.39%
All Time Low Date	2004-09-28
ATR	1.44
Beta	0.15
Beta1y	0.27
Beta2y	0.47
Ch YTD	-2.9
High	117
High52	132
High52 Date	2025-11-11
High52ch	-11.36%
Low	116
Low52	109.5
Low52 Date	2025-08-01
Low52ch	6.85%
Ma50ch	-1.64%
Price vs 200-day SMA	-2.05%
RSI	46.7
RSI Monthly	47.09
RSI Weekly	43.92
Sharpe ratio	0.09x
Sortino ratio	0.45
Total Return	4.61%
Tr YTD	-2.9
Tr15y	261.53%
Tr1m	-0.43%
Tr1w	1.74%
Tr3m	-1.68%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 670.3M
Operating Income Growth	4.21
Operating Income Growth Q	10.63
Operating Income Growth3 Y	5.04
Operating Income Growth5 Y	2.01
Operating margin	31.39

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	47,619,411%
Net Borrowing	-164,075,000
Shares Insiders	4.22%
Shares Institutions	5.97%
Shares Out	69,298,336
Shares Qo Q	0.71%
Shares Yo Y	0.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 607M
Average Volume	67,391.3x
Bv Per Share	52.05
CAPEX	TWD -57.2M
Ch10y	-29.52
Ch15y	103
Ch1m	-0.43
Ch1w	1.74
Ch1y	-7.14
Ch20y	1,025.8
Ch3m	-1.68
Ch3y	0.86
Ch5y	-2.9
Ch6m	-6.77
Change	0.86%
Change From Open	0.86
Close	116
Days Gap	0
Depreciation Amortization	155,351,000
Dollar Volume	4,928,157
Earnings Date	2026-03-12
EBIT	TWD 670.3M
EBITDA	TWD 825.6M
EPS	TWD 7.74
F Score	8
FCF	TWD 607M
FCF EV Yield	8.62x
FCF Per Share	TWD 8.76
Financing CF	-518,089,000
Fiscal Year End	December
Founded	1,991
Graham Number	95.21049
Graham Upside	-18.62
Income Tax	TWD 135.4M
Investing CF	-215,060,000
Is Primary Listing	1
Last Earnings Date	2025-11-10
Last Report Date	2025-12-31
Last Split Date	2015-08-20
Last Split Type	Reverse
Lynch Fair Value	TWD 38.7
Lynch Upside	-66.92
Ma150	120.8
Ma150ch	-3.12%
Ma20	118
Ma20ch	-0.85%
Net CF	-76,305,000
Open	116
P FCF Ratio	13.36
P OCF Ratio	12.21
Payment Date	2025-08-28
Position In Range	100
Ppne	2,280,230,000
Price Date	2026-05-08
Price EBITDA	TWD 9.82
Ptbv Ratio	2.25
Relative Volume	0.59x
Revenue	2,135,451,000x
Tax By Revenue	6.34x
Tax Rate	20.08%
Tr20y	2,261.92%
Tr6m	-6.77%
Volume	42,121
Z Score	6.94

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/4107 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.7%

$5.50 annual per share

Payout ratio

+64.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+4.6%

1 consecutive years of growth

Total shareholder yield

+4.6%

Next ex-dividend date: 2026-07-28

Performance

TPEX/4107 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4107?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.0%

Share of float held by funds and institutions

Insider ownership

+4.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

TPEX/4107 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.7

Neutral momentum band

Price vs 200-day MA

-2.1%

50/200-day relationship not available

Beta (5Y)

0.15

Less volatile than the market

Sharpe ratio

0.09

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4107

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4107 stock rating?

tpex/4107 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4107 analysis?

The full report lives at /stocks/tpex/4107/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4107?

The latest report frames tpex/4107 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4107 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.